Omeros Announces Upcoming Presentations of New Data on Omidria at the ASCRS Meeting

Omeros announced that the results of four studies directed to the benefits of Omidria across a range of clinical situations in cataract surgery will be presented at the upcoming American Society of Cataract and Refractive Surgery (ASCRS) Congress in Washington, D.C., April 13-17, 2018.

The four presentations are scheduled as follows:

Saturday, April 14: 1:41 PM – 1:46 PM
Walter E. Washington Convention Center – Room 143A
Miosis Prevention in Femtosecond-Assisted Cataract Surgery Using a Continuous Infusion of Phenylephrine and Ketorolac. Walter K, Delwadia N

Monday, April 16: 1:29 PM – 1:34 PM
Walter E. Washington Convention Center – Room 143B
Effect of Early Phenylephrine and Ketorolac Injection 1%/0.3% on Pupil Diameter in Traditional and Femtosecond-Assisted Cataract Surgery. Gayton J.

Monday, April 16: 2:08 PM – 2:13 PM
Walter E. Washington Convention Center – Room 143B
Effect of Phenylephrine and Ketorolac Injection on Intraoperative Floppy Iris Syndrome. Silverstein S., Rana V.

Monday, April 16: 2:13 PM – 2:18 PM
Walter E. Washington Convention Center – Room 143B
Clinical Outcomes of Phenylephrine/Ketorolac (1%/0.3%) vs. Epinephrine in Cataract Surgery in a Real-World Setting. Matossian C.